Mohamed Siddique
Psychiatry · Redford, MINPI 1114086857
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,521 and has fallen 95.6% since, to $155 in 2025. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $41.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- Alkermes, Inc.$2K
- Neurocrine Biosciences, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Johnson & Johnson$775
- AbbVie$698
- plus $2K from 13 others
What the payments were for
- Food & beverage$10,073100%
- Education$390%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 57 | $2,041 |
| Alkermes, Inc. | 28 | $1,656 |
| Neurocrine Biosciences, Inc. | 31 | $1,402 |
| Teva Pharmaceuticals USA, Inc. | 21 | $1,094 |
| Johnson & Johnson | 23 | $775 |
| AbbVie(2 entities) | 13 | $698 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $530 |
| Sunovion Pharmaceuticals Inc. | 5 | $500 |
| Corium, LLC | 11 | $276 |
| Axsome Therapeutics, Inc. | 2 | $248 |
| Supernus Pharmaceuticals, Inc. | 8 | $245 |
| Lundbeck LLC | 10 | $151 |
| Indivior Inc. | 6 | $111 |
| Tris Pharma Inc | 1 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $106 |
| Vanda Pharmaceuticals Inc. | 4 | $83 |
| Cleerly, Inc. | 1 | $30 |
| Shire North American Group Inc | 2 | $30 |
| Neos Therapeutics, LP | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$3,229
- REXULTI$1,074
- INGREZZA$970
- ARISTADA INITIO$807
- AUSTEDO$737
- VRAYLAR$600
- LATUDA$474
- LYBALVI$466
- CAPLYTA$375
- SPRAVATO$351
- Auvelity$248
- ABILIFY MAINTENA$231
- Azstarys$228
- QELBREE$132
- Austedo XR$125
- ABILIFY ASIMTUFII$121
- UZEDY$121
- Dyanavel XR$107
- INVEGA SUSTENNA$101
How this compares
$10,113 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.
Other psychiatry in Redford
- Abdul HafeezRedford$13K
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
- Samuel WedesLivonia$158K
- Arash JavanbakhtDetroit$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.